3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Breast Neoplasms
2
Radiation Injuries
1
Peripheral Nervous System Diseases
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Gangliosidosis, GM1
1
Gangliosidoses
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Brain Neoplasms
1
Interventions
Radiotherapy
24
Radiotherapy, Intensity-Modulated
8
Radiosurgery
6
Amifostine
5
Low-Level Light Therapy
4
Donepezil
4
Cisplatin
4
Carboplatin
4
Surveys and Questionnaires
3
Radiation
3
Proton Therapy
3
Paclitaxel
3
Neuropsychological Tests
3
Heavy Ion Radiotherapy
3
Etoposide
3
Chemotherapy, Adjuvant
3
Chemoradiotherapy
3
Brachytherapy
3
Bevacizumab
3
Surgical Procedures, Operative
2
Radiation Dose Hypofractionation
2
Patient Reported Outcome Measures
2
Mental Status and Dementia Tests
2
Esophagectomy
2
Androgen Antagonists
2
Adrenal Cortex Hormones
2
sodium propionate
1
sargramostim
1
olaparib
1
endostar protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Radiation Injuries
×
G(M1) Ganglioside
×
Clear all
NCT04395339
2024-08-01
GLORY
Sun Yat-sen University
Phase 3
Terminated
51 enrolled